Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Previous Page Next Page


An advantage of liquid biopsies is that it is a minimally invasive technique [1, 2]. It may also be used to detect a range of gene fusions (ALK, RET, ROS and NTRK1 gene fusions) from plasma, serum, circulating tumour cells, platelets and exosomes [1]. In addition, liquid biopsies can be performed over time during treatment and therefore can be used more easily than tissue biopsy for detecting molecular alterations arising during tumour evolution and those driving acquired resistance.


  1. Aguado C, Gimenez-Capitan A, Karachaliou N et al. Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients. Transl Lung Cancer Res 2016; 5: 525-531.
  2. Arneth B. Update on the types and usage of liquid biopsies in the clinical setting: a systematic review. BMC Cancer 2018; 18: 527.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings